In Vitro Antifungal-Drug Susceptibilities of Mycelial and Yeast Forms of Penicillium marneffei Isolates in Cambodia
Authors:
- 1 November 2006
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (11) , 4208-4210
Abstract
Penicillium marneffei infection is an important disease among human immunodeficiency virus patients in Southeast Asia. The in vitro antifungal-drug susceptibilities of 29 clinical isolates and 5 isolates from bamboo rats collected from 2002 to 2004 were determined. The P. marneffei yeast form is more susceptible than the mycelial form to amphotericin B and ketoconazole, while the mycelial and yeast forms displayed similar susceptibilities to flucytosine and itraconazole. The MICs of fluconazole were higher for both mycelial and yeast forms.Keywords
This publication has 20 references indexed in Scilit:
- Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniquesClinical Microbiology and Infection, 2005
- Susceptibility Testing of Fluconazole by the NCCLS Broth Macrodilution Method, E-Test, and Disk Diffusion for Application in the Routine LaboratoryJournal of Clinical Microbiology, 2002
- A Controlled Trial of Itraconazole to Prevent Relapse ofPenicillium marneffeiInfection in Patients Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1998
- Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimensAntimicrobial Agents and Chemotherapy, 1993
- Evolving Role of Flucytosine in Immunocompromised Patients: New Insights into Safety, Pharmacokinetics, and Antifungal TherapyClinical Infectious Diseases, 1992
- Disseminated Penicillium marneffei infection in HIV‐infected subjectHistopathology, 1992
- Penicillium marneffei Infection in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1992
- Penicillium marneffei: Another Pathogen to Consider in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1991
- Pharmacokinetics of itraconazole following oral administration to normal volunteersAntimicrobial Agents and Chemotherapy, 1988
- Pharmacokinetics and dose proportionality of ketoconazole in normal volunteersAntimicrobial Agents and Chemotherapy, 1986